VitalPath, a manufacturer of custom, highly complex catheter solutions, has acquired Modern Catheter Technologies (ModernCath), a manufacturer of advanced catheter delivery systems. The acquisition will increase VitalPath’s total footprint to more than 80,000 sq ft of manufacturing space, including 35,000 sq ft of ISO 7 and 8 cleanroom space. VitalPath customers will also gain access to additional expertise in key markets such as electrophysiology and neurovascular, particularly in microcatheters and peripheral vascular applications, the company reported in a news release.
“ModernCath is a strategic addition to expand and scale the VitalPath platform,” stated VitalPath CEO Randall Sword in the release. “ModernCath’s strength in the neurovascular and electrophysiology markets complements VitalPath’s expertise in the structural heart and peripheral markets. And their exceptional extrusion capabilities will be a valuable addition to our strength in laser processing technologies and finished device manufacturing.”
Added ModernCath president Doua Vang: “We are excited to join VitalPath and leverage complementary technologies to offer our customers a more complete catheter manufacturing solution. It was very important for us to partner with someone who not only understood our vision, but shared our willingness to take on complex catheter projects for the most demanding applications.”
ModernCath’s expertise in microcatheters strengthens VitalPath’s services for fast-moving customers in the neurovascular, coronary, and peripheral market segments. The deal builds on VitalPath’s acquisition of VitalDyne in March 2021.
VitalPath specializes in meeting challenging requirements such as single or multidirectional deflection, pushability, kink resistance, and torque response.
VitalPath is ISO 13485:2016 certified and FDA registered.